Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Efpeglenatide and cardiovascular outcomes in type 2 diabetes
Abstract Aims/hypothesis We aimed to determine whether the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) in individuals with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus decreases the risk of new-onset adverse cardiovascular events (CVEs) and mortality rate compared with other glucose-lowering drugs in a real setting at a population level
Despite that, he was still entertaining on the competitive stage, earning himself a large fanbase
However, the key USP family members involved in the TGF1-mediated profibrotic signaling pathway have not been fully clarified
US$ 20.86
US$ 25.30
US$ 23.37
US$ 27.35
US$ 27.35
